ArticleDigital health
Construction of an artificial intelligence system for the Los Angeles classification-based assessment of reflux esophagitis (with video).
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: This study aims to develop an artificial intelligence system capable of automatically classifying endoscopic images of reflux esophagitis (RE) according to the Los Angeles (LA) classification, thereby improving the accuracy and efficiency of RE diagnosis and providing intelligent support for clinical decision-making. Methods: RE images from three centers were collected to construct a dataset for training, validating, and testing a deep learning model. Model performance was evaluated using metrics such as accuracy, sensitivity, specificity, precision, area under the receiver operating characteristic curve (AUC), and F1 score. After model training, Grad-CAM (Gradient-weighted Class Activation Mapping) visualization techniques were applied to enhance model transparency. Finally, a clinical application was developed using PyQt5 technology for portable use. Results: Among the five models evaluated, YOLOv11l demonstrated the best performance, achieving an accuracy, precision, sensitivity, and F1 score of 97.89%, 94.90%, 93.69%, and 94.28% on the validation set, respectively; and a weighted average accuracy, precision, specificity, and AUC of 96.26%, 91.58%, 98.04%, and 0.995 on the test set. The diagnostic accuracy of this model was significantly higher than that of both junior (χ Conclusions: The artificial intelligence model and application developed based on the YOLOv11 network can rapidly and accurately grade the severity of RE according to the LA classification on retrospective external test data, providing a promising proof-of-concept system that warrants further prospective and multi-reader validation before routine clinical deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.